Back to top
more

Thermo Fisher Scientific (TMO)

(Delayed Data from NYSE)

$636.11 USD

636.11
1,698,526

+8.53 (1.36%)

Updated Dec 3, 2021 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.42%
2Buy19.05%
3Hold10.68%
4Sell6.41%
5Strong Sell3.08%
S&P50011.42%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 30% (176 out of 253)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Zacks News

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

3 Reasons to Add Accuray (ARAY) Stock to Your Portfolio

Investors continue to be optimistic about Accuray (ARAY) owing to its slew of software upgrades.

Cooper Companies (COO) Q4 Earnings Lag Estimates, Margins Up

Cooper Companies' (COO) fiscal fourth-quarter results reflect solid segmental and geographical performances.

Here's Why You Should Retain Allscripts (MDRX) Stock For Now

Investors continue to be optimistic about Allscripts (MDRX) owing to its strategic alliances and various innovation milestones.

Is Thermo Fisher Scientific (TMO) Outperforming Other Medical Stocks This Year?

Here is how Thermo Fisher Scientific (TMO) and West Pharmaceutical Services (WST) have performed compared to their sector so far this year.

Veeva Systems (VEEV) Q3 Earnings Beat Estimates, '22 View Up

Veeva Systems' (VEEV) fiscal Q3 results reflect impressive performances by both its segments.

Here's Why You Should Retain Boston Scientific (BSX) for Now

Investors are optimistic about Boston Scientific (BSX) owing to its solid third-quarter performance and impressive value-added acquisitions.

The Zacks Analyst Blog Highlights: Bunge, Expeditors, Tractor Supply Co, Watsco and Thermo Fisher Scientific

The Zacks Analyst Blog Highlights: Bunge, Expeditors, Tractor Supply Co, Watsco and Thermo Fisher Scientific

Patterson Companies (PDCO) Beats on Q2 Earnings & Revenues

Patterson Companies' (PDCO) fiscal second-quarter 2022 results benefit from strength in the Animal Health segment.

Here's Why You Should Invest in NextGen (NXGN) Stock Now

NextGen (NXGN) continues to gain momentum on the back of solid demand for its solutions and strength in EHR.

Fresenius Medical's (FMS) New Dialyzer to Boost Patient Outcome

Fresenius Medical's (FMS) latest dialyzer is expected to better serve dialysis patients because of its design.

Nalak Das headshot

Virus and Fed Dampen Investors' Morale: 5 Low-Beta Stock Picks

We have narrowed our search to five large-cap low-beta stocks that have provided higher returns than the market's benchmark the S&P 500 Index year to date. These are: TSCO, BG, EXPD, WSO and TMO.

DaVita (DVA) Study Favors mRNA Vaccines for Dialysis Patients

DaVita's (DVA) latest study indicates favorable outcomes for ESKD patients regarding the COVID-19 vaccines.

Here's Why You Should Hold on to Glaukos (GKOS) Stock Now

Glaukos Corporation (GKOS) continues to benefit from a robust product portfolio and solid performing iStent technology.

OPKO Health's (OPK) Arm Declares Readiness for COVID-19 Testing

OPKO Health's (OPK) BioReference Laboratories announces preparedness with respect to COVID-19 testing in the advent of the Omicron Variant.

3 Reasons to Retain Integer Holdings (ITGR) Stock For Now

Investors continue to be optimistic about Integer Holdings (ITGR) owing to its improving non-medical sales and its focus on growth strategies.

Here's Why You Should Retain DENTSPLY SIRONA (XRAY) Now

DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, forex woe persists.

Urmimala Biswas headshot

Quest Diagnostics' (DGX) COVID-19 Testing Demand Up in 3 Weeks

According to Quest Diagnostics (DGX), as the nation is entering the holiday season, the importance of testing service is gaining more importance with regard to minimizing the risk of community exposure of COVID-19.

Cooper Companies (COO) to Post Q4 Earnings: What's in Store?

Cooper Companies' (COO) fiscal fourth-quarter results are likely to reflect segmental strength.

What's in Store for Patterson Companies' (PDCO) Q2 Earnings?

Patterson Companies' (PDCO) fiscal second-quarter results are likely to reflect improvement at Dental segment.

Veeva Systems (VEEV) to Post Q3 Earnings: What's in Store?

Veeva Systems' (VEEV) fiscal third-quarter results are likely to reflect solid show by its segments and robust product portfolio.

Smith+Nephew (SNN) Rolls Out Robotic Assisted Surgical System

Smith+Nephew's (SNN) CORI system enables each patient to have a knee replacement that is shape-matched and aligned to their specific anatomy.

Urmimala Biswas headshot

Medtronic's (MDT) Q2 Earnings Beat, Revenues Lag Estimates

Medtronic (MDT) cuts revenue growth guidance for the full year on the projection of a severe pandemic impact to continue through the rest of the year.

Here's Why You Should Buy Thermo Fisher (TMO) Stock Now

Investors are optimistic about Thermo Fisher (TMO) on strength in end markets and raised 2021 guidance.

Here's Why You Should Retain Patterson Companies (PDCO) Stock

Patterson Companies (PDCO) continues to benefit from strength in Animal Health business and dental business.

PacBio's (PACB) Collaboration to Boost Rare Disease Diagnosis

PacBio's (PACB) recent partnership with ARUP Laboratories, with regard to a study, has the potential to enhance rare disease diagnosis.